Chrysostomi Gialeli

Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid

P.G. Dedes, Chrysostomi Gialeli, Anastasios Tsonis et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2012 · 81 citations

Medicine, Cancer Biology, Oncology +13

Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin‐like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells

Anastasios Tsonis, Nikolaos A. Afratis, Chrysostomi Gialeli et al. · FEBS Journal · 2013 · 54 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Imatinib as a key inhibitor of the platelet‐derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells

Christina J. Malavaki, Andreas E. Roussidis, Chrysostomi Gialeli et al. · FEBS Journal · 2013 · 51 citations

Life Sciences, Oncology, Pharmacology +17

Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer

Astrid Escudero‐Esparza, Michael Bartoschek, Chrysostomi Gialeli et al. · Oncotarget · 2016 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cartilage Oligomeric Matrix Protein initiates cancer stem cells through activation of Jagged1-Notch3 signaling

Michael Bartoschek, Carmen Rodríguez, Chrysostomi Gialeli et al. · Matrix Biology · 2018 · 47 citations

Life Sciences, Cell Biology, Oncology +14